Migraine DisordersAspirinMigraine with AuraMigraine without AuraTryptaminesPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalHeadacheHeadache DisordersTension-Type HeadacheSumatriptanPhotophobiaCortical Spreading DepressionTiclopidineErgotamineDihydroergotamineThromboxane B2Platelet AggregationCyclooxygenase InhibitorsPizotylineSalicylatesSerotonin Receptor AgonistsAnalgesicsPlatelet Function TestsNaproxenDrug Therapy, CombinationHeadache Disorders, PrimaryBlood PlateletsHeadache Disorders, SecondaryOphthalmoplegic MigraineDouble-Blind MethodRisk FactorsSodium SalicylateTreatment OutcomeFibrinolytic AgentsHyperacusisForamen Ovale, PatentCalcitonin Gene-Related PeptideHemorrhageAsthma, Aspirin-InducedDose-Response Relationship, DrugAnticoagulantsWarfarinProspective StudiesTablets, Enteric-CoatedIbuprofenStrokeHabituation, PsychophysiologicCyclooxygenase 1Meningeal ArteriesTrigeminal NucleiPain MeasurementBleeding TimeGastrointestinal HemorrhageTime FactorsCase-Control StudiesProstaglandin-Endoperoxide SynthasesPlatelet ActivationThromboxanesDura MaterThromboxane A2ComorbidityPrevalenceFlushingAcetaminophenThrombosisRandomized Controlled Trials as TopicTrigeminal GanglionQuestionnairesCyclooxygenase 2 InhibitorsFlunarizineRecurrenceDipyridamoleVertigoFollow-Up StudiesDrug ResistanceLipoxinsChronic DiseaseMyocardial InfarctionCross-Over StudiesCohort StudiesHydroxyzineIndomethacinTrigeminal Nucleus, SpinalCerebrovascular DisordersCardiovascular Diseases